Cochlear Limited Stock Today
| CHEOF Stock | USD 209.00 1.00 0.48% |
Performance5 of 100
| Odds Of DistressLess than 9
|
Cochlear is trading at 209.00 as of the 18th of April 2024. This is a -0.48% down since the beginning of the trading day. The stock's lowest day price was 209.0. Cochlear has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Cochlear Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of October 2023 and ending today, the 18th of April 2024. Click here to learn more.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear Ord operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 65.78 M outstanding shares. More on Cochlear Limited
Moving together with Cochlear Pink Sheet
| 0.87 | SYK | Stryker Financial Report 6th of May 2024 | PairCorr |
| 0.8 | BSX | Boston Scientific Corp Earnings Call This Week | PairCorr |
| 0.79 | SEMHF | Siemens Healthineers | PairCorr |
| 0.79 | SMMNY | Siemens Healthineers | PairCorr |
| 0.82 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cochlear Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cochlear's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cochlear or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Rick HollidaySmith |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Cochlear Limited [CHEOF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cochlear's market, we take the total number of its shares issued and multiply it by Cochlear's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cochlear Limited classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 65.78 M outstanding shares.
Cochlear Limited has accumulated about 629.3 M in cash with 376.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.57.
Check Cochlear Probability Of Bankruptcy
Ownership AllocationCochlear holds a total of 65.78 Million outstanding shares. 30% of Cochlear Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cochlear Ownership Details
Cochlear Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Cochlear jumping above the current price in 90 days from now is about 60.43%. The Cochlear Limited probability density function shows the probability of Cochlear pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Cochlear has a beta of 0.2405 suggesting as returns on the market go up, Cochlear average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cochlear Limited will be expected to be much smaller as well. Additionally, cochlear Limited has an alpha of 0.1131, implying that it can generate a 0.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Cochlear to move above the current price in 90 days from now is about 60.43 (This Cochlear Limited probability density function shows the probability of Cochlear Pink Sheet to fall within a particular range of prices over 90 days) .
Cochlear Limited Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cochlear market risk premium is the additional return an investor will receive from holding Cochlear long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cochlear. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cochlear's alpha and beta are two of the key measurements used to evaluate Cochlear's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.34 | |||
| Semi Deviation | 1.89 | |||
| Standard Deviation | 2.14 | |||
| Variance | 4.6 |
Cochlear Stock Against Markets
Picking the right benchmark for Cochlear pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cochlear pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cochlear is critical whether you are bullish or bearish towards Cochlear Limited at a given time. Please also check how Cochlear's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cochlear without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Cochlear Corporate Directors
Cochlear corporate directors refer to members of a Cochlear board of directors. The board of directors generally takes responsibility for the Cochlear's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cochlear's board members must vote for the resolution. The Cochlear board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Glen Boreham | Non-Executive Independent Director | Profile | |
| Yasmin Allen | Non-Executive Director | Profile | |
| Alison Deans | Non-Executive Independent Director | Profile | |
| Donal ODwyer | Non-Executive Director | Profile |
How to buy Cochlear Pink Sheet?
Before investing in Cochlear, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Cochlear. To buy Cochlear stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Cochlear. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Cochlear stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Cochlear Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Cochlear Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Cochlear Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Cochlear Limited?
The danger of trading Cochlear Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cochlear is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cochlear. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cochlear Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cochlear Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Cochlear Pink Sheet analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |